Michelle Robertson

Companies

• Geron CorporationChief financial officer Sep 27, 2023 to now¹
• Verastem OncologyBoard member Nov 17, 2021 to now²
• Editas MedicineChief financial officer Jan 10, 2020 to May 15, 2023³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Verastem Oncology VSTM52,666 shares⁴$461.9K at $8.77May 21, 2026
• Editas Medicine EDIT106,610 shares⁵$250.5K at $2.35May 11, 2023
• Geron Corporation GERN17,645 shares⁶$21.1K at $1.20Feb 18, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• May 21, 2026Granted 36,000 shares of Verastem Oncology⁴
• Feb 18, 2026Sold 9,855 shares at $1.94 of Geron Corporation⁶
• Feb 18, 2026Exercised options 27,500 shares of Geron Corporation⁶
• May 22, 2025Granted 8,333 shares of Verastem Oncology⁷
• Jun 18, 2024Granted 8,333 shares of Verastem Oncology⁸
• May 11, 2023Sold 949 shares at $9.87 of Editas Medicine⁵
• Mar 3, 2023Sold 184 shares at $8.89 of Editas Medicine⁹
• Mar 2, 2023Granted 31,500 shares of Editas Medicine⁹
• Feb 13, 2023Sold 4,287 shares at $9.67 of Editas Medicine¹⁰
• Jan 10, 2023Sold 1,752 shares at $8.16 of Editas Medicine¹¹
• Dec 5, 2022Sold 193 shares at $10.23 of Editas Medicine¹²
• Sep 6, 2022Sold 192 shares at $15.01 of Editas Medicine¹³
• Jun 3, 2022Sold 1,527 shares at $11.54 of Editas Medicine¹⁴
• Mar 3, 2022Sold 767 shares at $17.33 of Editas Medicine¹⁵
• Feb 10, 2022Granted 53,499 shares of Editas Medicine¹⁶
• Jan 11, 2022Sold 1,744 shares at $25.70 of Editas Medicine¹⁷
• Dec 22, 2021Granted 4,471 shares of Editas Medicine¹⁸